The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Brigatinib (Brand name: Alunbrig)
- Manufactured by
ARIAD Pharmaceuticals, Inc
FDA-approved indication: Treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib.
National Library of Medicine Drug Information Portal